Employment agreements with executive officers
| Officer | In this role | Joined | Source |
|---|---|---|---|
|
Rebecca Frey
Also a director
Chief Executive Officer
Title from the Form 4 dated Oct 29, 2026
|
Not stated | Not stated | |
|
Tyler Zeronda
Chief Financial Officer
Title from the Form 4 dated Oct 29, 2026
|
Since 2022
4 years
|
2019 | |
|
Rachael Alford
Chief Operating Officer
Title from the Form 4 dated Oct 29, 2026
|
Not stated | Not stated | |
|
Lori Payton
Chief Development Officer
Title from the Form 4 dated Oct 29, 2026
|
Not stated | Not stated | |
|
Steven Ryder
Chief Medical Officer
Title from the Form 4 dated Oct 29, 2026
|
Not stated | Not stated |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Nov 12, 2025 · updated by the 8-K of Jul 28, 2026
| Director | Age | On board | Independent | Committees | Other public boards | 2024 pay | Source |
|---|---|---|---|---|---|---|---|
|
Bill Lundberg
Joined Jul 27, 2026
Board chair
|
- | - | - |
audit committee
nominating and corporate governance committee · Chair
|
- | - | |
|
David Domzalski
CEO
|
59 |
2020
5 years
|
Not independent | None stated | None stated | Paid as CEO | |
|
Patrick LePore
Lead independent director
|
70 |
2020
5 years
|
Not stated | None stated | None stated | $146,775 | |
|
Steven Basta
|
60 |
2015
10 years
|
Not stated |
Audit
|
Phathom Pharmaceuticals, Inc. | $125,625 | |
|
Elisabeth Sandoval Little
|
63 |
2019
6 years
|
Not stated |
Audit
|
PROCEPT BioRobotics Corporation | $141,200 | |
|
Sharon Barbari
|
71 | Not stated | Not stated |
Compensation
Nominating and Corporate Governance
|
None stated | $143,988 | |
|
Rebecca Frey
Joined Jul 27, 2026
|
- | - | - | - | - | - | |
|
Mona Ashiya
Joined Jul 27, 2026
|
- | - | - |
compensation committee
|
- | - | |
|
Steven Hoerter
Joined Jul 27, 2026
|
- | - | - |
audit committee
compensation committee · Chair
|
- | - | |
|
Peter Silverman
Joined Jul 27, 2026
|
- | - | - |
compensation committee
nominating and corporate governance committee
|
- | - | |
|
William White
Joined Jul 27, 2026
|
- | - | - |
audit committee · Chair
nominating and corporate governance committee
|
- | - |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
Employment agreements with executive officers
Indemnification agreements requiring us to indemnify directors and executive officers to the fullest extent permitted by Delaware law
Loading...